Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Institut Curie
Gustave Roussy, Cancer Campus, Grand Paris
Gustave Roussy, Cancer Campus, Grand Paris
Centre Oscar Lambret
Children's Hospital of Philadelphia
DL Analytics
Centre Antoine Lacassagne
Emory University
Centre Hospitalier Universitaire de Nice
M.D. Anderson Cancer Center
Herlev and Gentofte Hospital
University of Arizona
National Cancer Institute (NCI)
University of New Mexico
Elsan
Hoffmann-La Roche
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana
AdventHealth
Yale University
National Cancer Institute (NCI)
University of Sao Paulo